Hints and tips:
Related Topics
...Assimakis Komninos, a partner at law firm White & Case, and who is not involved in either Illumina case, said: “It makes sense for Illumina to wait because if it wins before the Court of Justice on a separate...
...Illumina is appealing against the fine. In October, Brussels also ordered Illumina to sell Grail. Illumina said on Thursday it expected to unwind the transaction during the second quarter of this year....
...Illumina intends to appeal any order to sell Grail, according to people familiar with the matter. Illumina and the European Commission declined to comment....
...Last month, Illumina disclosed that the US Securities and Exchange Commission was investigating its acquisition of Grail....
...He also took it as an opportunity to call out Illumina’s board....
...Illumina’s merger with Grail is pro-competitive and in the best interests of patients in Europe and worldwide.”...
...Illumina had disputed the EU’s right to scrutinise the deal, pointing to the fact that Grail does not have any revenues in Europe....
...Illumina said there is no severance payment associated with the resignation....
...Illumina declined to comment....
...In December, Brussels ordered Illumina to divest Grail and is planning to issue a fine worth up to $453mn for “gun jumping”. The US Federal Trade Commission has also ordered Illumina to divest Grail....
...Illumina shares closed up 7.8 per cent on Wednesday....
...Icahn, who has a 1.4 per cent stake in Illumina, has alleged its board lacks independence and most directors were handpicked by deSouza. He has nominated three directors to Illumina’s board....
...He has won board seats at utility AEP and airline JetBlue after building large stakes in the companies, and continues to pressure genomics specialist Illumina after ousting some of its directors last year...
...He recently won board seats at utility AEP and airline JetBlue, and continues to pressure genomics specialist Illumina after ousting some of its directors last year....
...Illumina is running Grail as a subsidiary while it battles the EU order....
...Illumina’s battle with antitrust regulators has sparked a proxy battle with activist investor Carl Icahn, who claims the deal cost Illumina up to $50bn in market value....
...Illumina shares ended the day 17 per cent higher at $226.94 in New York....
...On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina’s decision to proceed....
...Clips from Illumina Inc / Seeking Alpha, Yahoo For further reading: Carl Icahn takes aim at genome sequencer Illumina over Grail deal Has Illumina taken the wrong path in its Grail quest?...
...Stocks such as Thermo Fisher and Illumina, held by Liontrust, have not done well as growth flattened after the post-Covid boom....
...following any forced divestment by Illumina....
...Francis deSouza, who departed Illumina unceremoniously as chief executive, will not stand for re-election. Hargreaves Lansdown has appointed Alison Platt as board chair....
...Illumina said it no longer employs Cameron as a paid adviser....
...Icahn’s campaign against Illumina is one of the biggest activist scraps in years....
International Edition